Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Company is going to participate in Avendus Spark Investor Conference 2023 at Mumbai on August 17, 2023.10-08-2023
10-08-2023
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Closing of acquisition08-08-2023
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Further to our letter dated August 1, 2023 intimating about the Q1 FY24 post results earning call details, please note that there is change in the time of same. The revised timings are: 3:00 p.m. to 4:00 p.m. on Friday, August 11, 2023. Day and date remains unchanged.04-08-2023
Zydus Lifesciences Ltd - 532321 - Changes In Senior Management
Changes in Senior Management03-08-2023
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Indomethacin Suppository with competitive generic therapy designation03-08-2023
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Q1 FY24 Post results Earnings Call details01-08-2023
Zydus Lifesciences Ltd - 532321 - Board Meeting Intimation for Notice For The Meeting Of Board Of Directors
Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 ,inter alia, to consider and approve the unaudited financial results for the quarter ended on June 30, 2023.31-07-2023
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Plerixafor Injection USP, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial.27-07-2023
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Updates on Joint Venture
The Company, as a joint venture partner, has signed an agreement to amend certain clauses of the joint venture agreement ("JVA") with Bayer (South East Asia) PTE Limited, one of the companies of the Bayer group.27-07-2023
Zydus Lifesciences Ltd - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate under Reg 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201526-07-2023